Jin Medical International Ltd. Files 6-K Report
Ticker: ZJYL · Form: 6-K · Filed: Aug 20, 2025 · CIK: 1837821
| Field | Detail |
|---|---|
| Company | Jin Medical International Ltd. (ZJYL) |
| Form Type | 6-K |
| Filed Date | Aug 20, 2025 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 6-K, foreign-private-issuer, regulatory-filing
TL;DR
Jin Medical Intl (JMEI) filed a 6-K on Aug 20 for Q1 2025. Standard foreign issuer report.
AI Summary
Jin Medical International Ltd. filed a Form 6-K on August 20, 2025, reporting for the period ending March 31, 2025. The company, incorporated in E9 and headquartered in Changzhou City, Jiangsu Province, China, operates in the orthopedic, prosthetic & surgical appliances & supplies industry. This filing is a report of a foreign private issuer.
Why It Matters
This filing provides an update on the company's reporting status as a foreign private issuer, which is relevant for investors tracking its regulatory compliance and financial disclosures.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain significant new financial information or material events.
Key Players & Entities
- Jin Medical International Ltd. (company) — Registrant
- August 20, 2025 (date) — Filing Date
- March 31, 2025 (date) — Reporting Period End Date
- Changzhou City, Jiangsu Province, People's Republic of China (location) — Principal Executive Office
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of August 2025.
What is the reporting period for this filing?
The conformed period of report is March 31, 2025.
Where is Jin Medical International Ltd. headquartered?
The company's principal executive office is located at No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, People's Republic of China.
Does Jin Medical International Ltd. file annual reports under Form 20-F or Form 40-F?
Yes, the registrant indicates it files annual reports under cover of Form 20-F.
What is the SIC code for Jin Medical International Ltd.?
The Standard Industrial Classification code is 3842, for Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Filing Stats: 996 words · 4 min read · ~3 pages · Grade level 13.6 · Accepted 2025-08-20 17:15:40
Filing Documents
- ea0254048-6k_jinmedical.htm (6-K) — 27KB
- ea025404801ex99-1_jinmedical.htm (EX-99.1) — 744KB
- ea025404801ex99-2_jinmedical.htm (EX-99.2) — 157KB
- 0001213900-25-079036.txt ( ) — 6514KB
- zjyl-20250331.xsd (EX-101.SCH) — 69KB
- zjyl-20250331_cal.xml (EX-101.CAL) — 69KB
- zjyl-20250331_def.xml (EX-101.DEF) — 331KB
- zjyl-20250331_lab.xml (EX-101.LAB) — 545KB
- zjyl-20250331_pre.xml (EX-101.PRE) — 355KB
- ea0254048-6k_jinmedical_htm.xml (XML) — 802KB
Financial Statements and Exhibits
Financial Statements and Exhibits. Exhibits : Exhibit No. Description 99.1 Unaudited Condensed Consolidated Financial Statements as of March 31, 2024 and for the Six Months Ended March 31, 2025 and 2024. 99.2 Operating and Financial Review and Prospects in Connection with the Unaudited Condensed Consolidated Financial Statements for the Six Months March 31, 2025 and 2024. 101.INS Inline XBRL Instance Document 101.SCH Inline XBRL Taxonomy Extension Schema Document. 101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document. 101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document. 101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document. 101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Jin Medical International Ltd . Date: August 20, 2025 By: /s/ Erqi Wang Erqi Wang Chief Executive Officer By: /s/ Ziqiang Wang Ziqiang Wang Chief Financial Officer 3